15.7.2004 _EN | Official Journal of the European Union L 243/15 COMMISSION REGULATION (EC) No 1289/2004 of 14 July 2004 concerning the authorisation for 10 years of the additive Deccox® in feedingstuffs, belonging to the g ye cc g ging group of coccidiostats and other medicinal substances (Text with EEA relevance) THE COMMISSION OF THE EUROPEAN COMMUNITIES, Having regard to the Treaty establishing the European Community, Having regard to Council Directive 70/524/EEC of 23 November 1970 concerning additives in feedingstuffs ('), as last amended by Council Regulation (EC) No 1756/2002 (3), and in particular Article 9g(5)(b) thereof, Whereas: As provided for in Article 9g(1) of Directive 70/524/EEC, coccidiostats included in Annex I to that Directive before 1 January 1988 were provisionally authorised as from 1 April 1998 and transferred to Chapter I of Annex B with a view to their re-evaluation as additives linked to a person responsible for putting them into circulation. New applications for authorisation had to be submitted for the abovementioned additives. Furthermore, Article 9g(4) of Directive 70/524/EEC required that the dossiers in respect of these applications be submitted no later than 30 September 2000, with a view to re- evaluation. The data had to be produced as provided for in Article 4 of that Directive. Article 9g(5) of Directive 70/524 EEC provides that, after re-evaluation of the dossiers submitted, the provisional authorisation of the additives concerned be withdrawn or, as the case may be, be replaced by an authorisation linked to the person responsible for putting them into circulation for a period of 10 years through the adoption of a regulation taking effect no later than 1 October 2003. The person responsible for putting into circulation the decoquinate product (Deccox®), an additive belonging to the group ‘Coccidiostats and other medicinal substances’ listed in Chapter I of Annex B to Directive 70/524/EEC, submitted an application for authorisation and a dossier, in conformity with Article 9g(2) and (4) of that Directive. () O] L 270, 14.12.1970, p. 1. () O] L 265, 3.10.2002, p. 1. ©) ) () The Parliament and Council Regulation (EC) No 178 of 28 January 2002 regarding the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matter of food safety(®), as amended by Regulation (EC) No 1642/2003 (*), established the European Food Safety Authority (EFSA) took over the role of the Scientific Committees attached to the Commission in issuing scientific opinions in its field of competences. The Scientific Panel on Additives and Products or Substances used in Animal Feed has delivered a favourable opinion with regard to the safety and to the efficacy of Deccox® based on the decoquinate for chickens for fattening. The Commission took all necessary measures to ensure that re-evaluation of the decoquinate product (Deccox®) be completed within the time-frame provided by Article 9g(5) of Directive 70/524/EEC. Their evaluation showed that the relevant conditions laid down in Directive 70/524[EEC are satisfied in order to include Deccox® based on the decoquinate in Chapter I of the list referred to Article 9t(b) of the said Directive, as an additive linked to the person responsible for putting it into circulation authorised for a period of 10 years. Article 9g(6) of Directive 70/524/EEC allows the automatic extension of the period of authorisation of the additives concerned until the Commission takes a decision in case of, for reasons beyond the control of the authorisation holder, no decision may be taken on the application before the expiry date of the authori- sation. This provision is applicable to the authorisation of Deccox® based on the decoquinate. Several requests for additional information were made during the re- evaluation process, extending the evaluation period for reason beyond the control of the person responsible for putting into circulation the product concerned. Article 9m of Directive 70/524EEC foresees that an additive may continue to be authorised in order to use the stocks if the condition laid down in Article 3a(b) and (e) continue to be met. Since there are no safety reasons for withdrawing immediately the decoquinate product from the market, it is appropriate to allow a transitional period of six months for the disposal of existing stocks of the additive. 31, 1.2.2002, p. 1. oJ L 0] L 245, 29.9.2003, p. 4.